Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmunaBand was a U.S. digital-health and wearable-device company launched in early 2021 to provide QR-enabled wristbands that displayed and linked to an individual's COVID-19 vaccination documentation. The company marketed a consumer bracelet product and an enterprise software offering called ImmunaWork, which allowed employers to manage workforce vaccination records and booster reminders. Its products were positioned as HIPAA-compliant, encrypted tools for vaccination-status verification during the COVID-19 reopening period. Publicly available evidence indicates the business was tied to ImmunaBand LLC and related trademark filings by VaxiBand LLC, but there is little evidence of an ongoing active operating presence after 2021-2022. The company does not appear to have developed therapeutic drugs or a traditional biopharma pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImmunaBand.